Chordia Therapeutics (TSE:190A) Receivables Turnover : 0.00 (As of Feb. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Chordia Therapeutics's Revenue for the three months ended in Feb. 2025 was 円0.00 Mil. Chordia Therapeutics's average Accounts Receivable for the three months ended in Feb. 2025 was 円0.00 Mil.

Chordia Therapeutics Receivables Turnover Historical Data

The historical data trend for Chordia Therapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Receivables Turnover Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Receivables Turnover

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	May23	Aug23	May24	Aug24	Feb25
Receivables Turnover	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Chordia Therapeutics's Receivables Turnover

For the Biotechnology subindustry, Chordia Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordia Therapeutics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Chordia Therapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Chordia Therapeutics's Receivables Turnover for the fiscal year that ended in Aug. 2024 is calculated as

	Receivables Turnover (A: Aug. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Aug. 2024 )	/ (	(Accounts Receivable (A: Aug. 2023 )	+	Accounts Receivable (A: Aug. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Chordia Therapeutics's Receivables Turnover for the quarter that ended in Feb. 2025 is calculated as

	Receivables Turnover (Q: Feb. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Feb. 2025 )	/ (	(Accounts Receivable (Q: Aug. 2024 )	+	Accounts Receivable (Q: Feb. 2025 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Chordia Therapeutics (TSE:190A) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Chordia Therapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines